Cesca Therapeutics’ Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR-T Manufacturing Process … – Nasdaq
|
Cesca Therapeutics’ Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR–T Manufacturing Process …
Nasdaq Cesca Therapeutics Inc. (the “Company”) develops, commercializes and markets a range of automated technologies for CAR–T and other cell-based therapies. Its device division, ThermoGenesis Corp., provides a full suite of solutions for automated clinical … |
Genetic Literacy Project |
CRISPR plants are on the way—but gene-edited animals face more barriers
Genetic Literacy Project But the FDA announced that they view CRISPR in animals as a form of gene therapy, which means it’s regulated as a veterinary drug. So if you want to use CRISPR to produce a hornless cow, or a purebred dog that’s missing one of the harmful mutations … |
Xconomy |
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”
Xconomy Xconomy Boston —. CAR-T. Gene therapy. RNA interference. These aren’t just science experiments. They’re real, cutting-edge medicines either just on the market or soon to be. And the implications of their arrival was the focus of a few spirited … |
U.S. News & World Report |
What to Know About Allergy Immunotherapy
U.S. News & World Report You’ve probably seen or heard the medical news about cancer treatments called immunotherapy. This breakthrough approach is a way to change your immune system to fight cancer without toxic drugs. But for over 100 years another type of immunotherapy … |